AURX Nuo Therapeutics, Inc.

CIK 0001091596 19 ready 8-Ks latest June 2, 2026, 5:41 PM ET RSS · JSON

Activity: NORMAL 0 filings / 30d vs 0 baseline

Ready 8-Ks 19

Latest filing June 2, 2026, 5:41 PM ET

Top materiality 0.70

Event mix other_material ×13 · other ×3 · debt ×2

Sentiment 2 pos · 2 neg · 15 neu

Recent 8-K filings for AURX

Highest-materiality recent filing

Nuo Therapeutics secures $2M loan facility; issues warrants at $1.50 strike

June 2, 2026, 5:41 PM ET debt materiality 0.70 neutral item 1.01 item 2.03 item 3.02 item 9.01 ◈ Debt Financings◈ Equity Issuances◈ Material Agreements

Amended loan agreement increases aggregate commitment by $400k to $2.0M; $675k funded on May 29, 2026.
Interest rate raised to 12% on all outstanding notes; interest payable via warrants, not cash.

Read filing →

June 2, 2026, 5:41 PM ET debt materiality 0.70 neutral item 1.01 item 2.03 item 3.02 item 9.01 ◈ Debt Financings◈ Equity Issuances◈ Material Agreements

Nuo Therapeutics secures $2M loan facility; issues warrants at $1.50 strike

Amended loan agreement increases aggregate commitment by $400k to $2.0M; $675k funded on May 29, 2026.
May 14, 2026, 5:11 PM ET earnings materiality 0.60 positive item 2.02 item 9.01 ◈ Earnings Releases

Nuo Therapeutics Q1 revenues up 169% YoY to $1.3M; operating loss narrows

Total revenue $1.3M, including $1.22M product sales, up 169% YoY and 20% sequential.
January 26, 2026, 6:59 PM ET debt materiality 0.65 neutral item 1.01 item 2.03 item 3.02 item 9.01 ◈ Debt Financings◈ Equity Issuances◈ Material Agreements

Nuo Therapeutics secures up to $1.6M loan with 10%-12% PIK interest paid in warrants; insider participation

Loan agreement for $1.0M initial + $600K second tranche (Sept 30, 2026); $1.0M funded Jan 23, 2026.
June 11, 2024, 7:59 PM ET other material materiality 0.65 negative item 4.01 item 9.01

Nuo Therapeutics dismisses auditor Marcum, engages MaloneBailey; cites material weaknesses

Effective June 7, 2024, dismissed Marcum LLP as independent auditor; engaged MaloneBailey, LLP for FY 2024.
August 30, 2022, 7:59 PM ET other material materiality 0.65 positive item 1.01 item 7.01 item 9.01

Nuo Therapeutics secures $500K equity investment from distributor Pacific Medical; raises $4.5M YTD

PacMed invests $500K for 500K shares at $1.00; receives two warrants for up to 450K shares tied to sales quotas.
May 2, 2022, 7:59 PM ET other material materiality 0.65 neutral item 1.01 item 3.02 item 9.01

Nuo Therapeutics raises $3.55M in private placement at $1.00/share with insider participation

Sold 3,550,000 shares of common stock at $1.00 per share for gross proceeds of $3,550,000.

Materiality & sentiment trend

Max materiality 0.70 · Median 0.50 · Most common event other_material

2 positive 2 negative 15 neutral

source · AURX on sec.gov